Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Intangibles (2021 - 2025)

Bioregenx's Intangibles history spans 5 years, with the latest figure at $725000.0 for Q3 2025.

  • Quarterly results put Intangibles at $725000.0 for Q3 2025, down 93.58% from a year ago — trailing twelve months through Sep 2025 was $725000.0 (down 93.58% YoY), and the annual figure for FY2023 was $49363.0, up 31.73%.
  • Intangibles for Q3 2025 was $725000.0 at Bioregenx, roughly flat from $725000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $11.3 million in Q3 2024 to a low of $33023.0 in Q3 2023.
  • The 5-year median for Intangibles is $49363.0 (2023), against an average of $3.1 million.
  • The sharpest move saw Intangibles soared 34099.3% in 2024, then crashed 93.58% in 2025.
  • Year by year, Intangibles stood at $43404.0 in 2021, then dropped by 13.66% to $37473.0 in 2022, then soared by 31.73% to $49363.0 in 2023, then skyrocketed by 22778.75% to $11.3 million in 2024, then crashed by 93.58% to $725000.0 in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $725000.0, $725000.0, and $11.3 million for Q3 2025, Q2 2025, and Q3 2024 respectively.